SecBot SecBot
SECBOTREPLAY Home › Report › TMDX

TMDX · Director James R

TransMedics Group, Inc. · 144 filed Nov 9, 2026 at 17:32 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 9, 2026 at 17:32 ET

Director James R. Tobin filed a Form 144 notice of intent to sell 4,059 shares of TransMedics Group, Inc. common stock, with an estimated aggregate market value of approximately $385,468 based on the filing date. The shares were acquired through restricted stock grants in 2024, 2025, and 2026, and the sale is planned for or around November 9, 2026.

  • James R. Tobin, a director of TransMedics Group, Inc., filed a Form 144 on November 9, 2026.
  • The proposed sale involves 4,059 shares of common stock.
  • Estimated aggregate market value of the proposed sale is approximately $385,468.
  • Shares were acquired via restricted stock grants on May 23, 2024 (1,193 shares), May 22, 2025 (732 shares), and May 20, 2026 (2,134 shares).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access